@article{81bc68f77d5b4134be3229633d4c9367,
title = "ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery. Case for a European multicenter study",
author = "Seal, {David V.} and Peter Barry and George Gettinby and Fiona Lees and Magnus Peterson and Revie, {Crawford W.} and Wilhelmus, {Kirk R.}",
note = "Funding Information: The ESCRS first envisioned the need for this study in 1995, with 3 grant applications made to the EU (1996, 1998, and 2000). However, none of the grant applications was funded, so industrial support was investigated. In 2001, the ESCRS approached Santen GmbH. Santen agreed to supply 17 500 drop bottles of levofloxacin 0.5% and 17 500 of its antibiotic-free vehicle solution (placebo) as well as the antibiotic Oftaquix (levofloxacin 0.5%) for postoperative prophylaxis. The ESCRS Board and Santen agreed to fund the balance of costs on a 70–30 basis. The protocol was written in 2002, and indemnity insurance was purchased in January 2003 as a 3-year policy for 300 000 euros as this was required to make hospital ethical committee applications. Further insurance of 65 000 euros was required for German and Polish centers. The first hospital started to recruit patients for the study in September 2003; however, most partners were not fully active in the study until early 2004. ",
year = "2006",
month = mar,
doi = "10.1016/j.jcrs.2006.02.014",
language = "English",
volume = "32",
pages = "396--406",
journal = "Journal of Cataract and Refractive Surgery",
issn = "0886-3350",
publisher = "Elsevier Inc.",
number = "3",
}